×

Shares in Vertex jump on overnight success of CF triple therapy

Shares in US pharma Vertex were up sharply in premarket trading after its newly-launched cystic fibrosis triple therapy attained blockbuster status almost overnight, leading to a surprise upgrade to its sales forecasts for the coming year.  This was the first set of results announced under new CEO Reshma Kewalramani, who…